DeepOncology AI

Visual Detection Technology for Liver Cancer

Health Tech & Life Sciences
Non Active, Oct 2021 ceased to operate
Pre-Funding Tel Aviv-Yafo Founded 2018
Total raised
Stage
Pre-Funding
Founded
2018
Headcount
1-10
HQ
Tel Aviv-Yafo
Sector
Health Tech & Life Sciences

About

DeepOncology AI utilizes deep learning techniques in the fields of radiology and oncology to facilitate clinical cancer research and diagnosis. The company addresses the critical need for automated analysis tools to screen for liver metastases using 3D imaging. The integration of oncology, artificial intelligence, and computer vision has led to technology for the visual detection of liver cancer, one of the deadliest cancer types. DeepOncology AIs DeepOn device offers prospects for precise tumor characterization and early diagnosis and treatment. DeepOncologys express goal is to act as a facilitator between imaging science and clinical research, integrating oncology, radiology, artificial intelligence, and computer vision in clinically significant imaging applications. Through professional, empirical research the company aims to aid in the fight against cancer, where the result of a days work is wholly tangible and of direct benefit to peoples lives.

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesDigital HealthcareMedical Decision Support
Technologies
Artificial IntelligenceComputer Vision
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2B

Highlights

Verified

Tags

digital-healthcareradiologynon-invasivehealthcare-providershospitalsclinicsdoctorscomputer-visioncanceroncologyartificial-intelligencemedical-devicesdiagnosticsdecision-support